Patent Assignment
Reel/Frame 031722/0709
Change of Name
Recorded: 2013-12-05
Pages: 7
Assignor
ABBOTT BIOTHERAPEUTICS CORP
Executed: 2012-11-26
Assignee
ABBVIE BIOTHERAPEUTICS INC.
1500 SEAPORT BLVD, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(3)
Recombinant Antibody-Toxin Fusion Protein
Patent:
5,863,745 →
Application:
08/461,825 →
Tethered Vectors for Cell Surface Immunoglobulin Display
Anti-Egfr Antibodies and Their Uses
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 26, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 018303/0026 →
Assignment of Assignor's Interest
May 23, 2008
From: AKAMATSU, YOSHIKO; TSURUSHITA, NAOYA
To: PDL BIOPHARMA INC.
Reel/Frame 020991/0849 →
Assignment of Assignor's Interest
Apr 13, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 022537/0310 →
Assignment of Assignor's Interest
Dec 15, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023649/0752 →
Change of Name
Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name
Dec 9, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025483/0591 →
Assignment of Assignor's Interest
Feb 11, 2011
From: AKAMATSU, YOSHIKO; DUBRIDGE, ROBERT B.; POWERS, DAVID B.
To: ABBOTT BIOTHERAPEUTICS CORPORATION
Reel/Frame 025796/0824 →
Assignment of Assignor's Interest
Dec 3, 2013
From: FORSYTH, CHARLES M.
To: ABBOTT BIOTHERAPEUTICS CORPORATION
Reel/Frame 031708/0746 →